HEALIOS K.K. FY2025 Q3 Earnings Report | IR Tracker

HEALIOS K.K. FY2025 Q3 Earnings Report | IR Tracker

Financial Highlights

Net Sales: ¥79M
Operating Income: ¥-2.33B
Net Income: ¥-4.15B
EPS: ¥-39.49

Income Statement

Item	Current	Prior	YoY %
Net Sales	¥79M	¥542M	-85.4%
Cost of Sales	¥142M	¥98M	+44.9%
Gross Profit	¥-63M	¥444M	-114.2%
SG&A Expenses	¥796M	¥1.00B	-20.6%
Operating Income	¥-2.33B	¥-1.98B	-18.1%
Equity Method Investment Income	¥-1M	¥-2M	+50.0%
Profit Before Tax	¥-4.13B	¥-4.50B	+8.2%
Income Tax Expense	¥11M	¥-29M	+137.9%
Net Income	¥-4.15B	¥-4.47B	+7.4%
Net Income Attributable to Owners	¥-4.15B	¥-4.49B	+7.7%
Total Comprehensive Income	¥-4.17B	¥-4.47B	+6.8%
Basic EPS	¥-39.49	¥-51.08	+22.7%
Diluted EPS	¥-39.49	¥-51.08	+22.7%
Dividend Per Share	¥0.00	¥0.00	-

Balance Sheet

Item	Current End	Prior End	Change
Current Assets	¥7.17B	¥4.28B	+¥2.90B
Accounts Receivable	¥189M	¥184M	+¥5M
Non-current Assets	¥10.16B	¥9.92B	+¥240M
Property, Plant & Equipment	¥399M	¥403M	¥-4M
Intangible Assets	¥4.42B	¥4.42B	¥-5M

Cash Flow Statement

Item	Current	Prior	Change
Operating Cash Flow	¥-2.33B	¥-1.24B	¥-1.09B
Investing Cash Flow	¥-756M	¥-580M	¥-176M
Financing Cash Flow	¥5.97B	¥-361M	+¥6.33B
Cash and Cash Equivalents	¥6.50B	¥3.67B	+¥2.83B
Free Cash Flow	¥-3.08B	-	-

Profitability Ratios

Item	Value
Net Profit Margin	-5248.1%
Gross Profit Margin	-79.7%
Debt-to-Equity Ratio	4.86x
Effective Tax Rate	-0.3%

Year-over-Year Comparison

Item	YoY Change
Net Sales YoY Change	-85.5%

Item	Value
Shares Outstanding (incl. Treasury)	115.45M shares
Treasury Stock	300 shares
Average Shares Outstanding	105.00M shares
Book Value Per Share	¥25.59

Dividend Information

Item	Amount
Q2 Dividend	¥0.00
Year-End Dividend	¥0.00

Full Year Forecast

Item	Forecast
Dividend Per Share Forecast	¥0.00